索引超出了数组界限。
[1] Batra P, Dwivedi AK, Thakur N. Bedside ABG, electrolytes, lactate and procalcitonin in emergency pediatrics[J]. Int J Crit Illn Inj Sci, 2014, 4(3):247-252.
[2] Lecharny JB, Khater D, Bronchard R, et al. Hyperprocalcitonemia in patients with perioperative myocardial infarction after cardiac surgery[J]. Crit Care Med, 2001, 29(2):323-325.
[3] Prat C, Ricart P, Ruyra X, et al. Serum concentrations of procalcitonin after cardiac surgery[J]. J Card Surg, 2008, 23(6):627-632.
[4] Gao H, Zhang N, Lu F, et al. Circulating histones for predicting prognosis after cardiac surgery: a prospective study[J]. Interact Cardiovasc Thorac Surg, 2016, 23(5):681-687.
[5] Becker KL, Snider R, Nylen ES. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target[J]. Br J Pharmacol, 2010, 159(2):253-264.
[6] Bobillo-Perez S, Rodríguez-Fanjul J, Jordan Garcia I. Is procalcitonin useful in pediatric critical care patients?[J]. Biomark Insights, 2018, 13:1177271918792244.
[7] Kiszewska N, Ewa Bień, Irga-Jaworska N, et al. Selected inflammatory markers in the diagnosis and monitoring of infections in children treated for hematological malignancies[J]. Biomark Med, 2015, 9(5):461-471.
[8] Pierce R, Bigham MT, Giuliano JS. Use of procalcitonin for the prediction and treatment of acute bacterial infection in children[J]. Curr Opin Pediatr, 2014, 26(3):292-298.
[9] Heredia-Rodríguez M, Bustamante-Munguira J, Lorenzo M, et al. Procalcitonin and white blood cells, combined predictors of infection in cardiac surgery patients[J]. J Surg Res, 2017, 212:187-194.
[10] Li X, Wang X, Li S, et al. Diagnostic value of procalcitonin on early postoperative infection after pediatric cardiac surgery[J]. Pediatr Crit Care Med, 2017, 18(5):420-428.
[11] Tosoni A, Paratore M, Piscitelli P, et al. The use of procalcitonin for the management of sepsis in Internal Medicine wards: current evidence[J]. Panminerva Med, 2020, 62(1):54-62.
[12] Gibot S, Béné MC, Noel R, et al. Combination biomarkers to diagnose sepsis in the critically ill patients[J]. Am J respire Crit Care Med, 2012, 186(1):65-71.
[13] Meer WVD, Pickkers P, Scott CS, et al. Hematological indices, inflammatory markers and neutrophil CD64 expression: Comparative trends during experimental human endotoxemia[J]. J Endotoxin Res, 2007, 13(2):94-100.
[14] Matsui T, Ohsumi K, Ozawa N, et al. CD64 on neutrophils is a sensitive and specific marker for detection of infection in patients with rheumatoid arthritis[J]. J Rheumatol, 2006, 33(12):2416-2424.
[15] Groselj-Grenc M, Ihan A, Pavcnik-Arnol M, et al. Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children[J]. Intensive Care Med, 2009, 35(11):1950-1958.
[16] Bhandari V, Wang C, Rinder C, et al. Hematologic profile of sepsis in neonates: neutrophil CD64 as a diagnostic marker[J]. Pediatrics, 2008, 121(1):129-134.
[17] Nuutila J. The novel applications of the quantitative analysis of neutrophil cell surface FcγRI(CD64)to the diagnosis of infectious and inflammatory diseases[J]. Curr Opin Infect Dis, 2010, 23(3):268-274.
[18] Groselj-Grenc M, Ihan A, Pavcnik-Arnol M, et al. Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children[J]. Intensive Care Med, 2009, 35(11):1950-1958.
[19] Cardelli P, Ferraironi M, Amodeo R, et al. Evaluation of neutrophil CD64 expression and procalcitonin as useful markers in early diagnosis of sepsis[J]. Int J Immunopathol Pharmacol, 2008, 21(1):43-49.
[20] Hsu KH, Chan MC, Wang JM, et al. Comparison of Fcgamma receptor expression on neutrophils with procalcitonin for the diagnosis of sepsis in critically ill patients[J]. Respirology, 2011, 16(1):152-160.
[21] Djebara S, Biston P, Emmanuel Fossé, et al. Time course of Cd64, a leukocyte activation marker, during cardiopulmonary bypass surgery[J]. Shock, 2016, 47(2):158-164.
[22] Daix T, Guerin E, Tavernier E, et al. Multicentric standardized flow cytometry routine assessment of septic patient to predict clinical worsening[J]. Chest, 2018, 154(3):617-627.
[23] Guérin, Estelle, Orabona M, Raquil MA, et al. Circulating immature granulocytes with T-cell killing functions predict sepsis deterioration[J]. Crit Care Med, 2014, 42(9):2007-2018.
[24] Orr Y, Wilson DP, Taylor JM, et al. A kinetic model of bone marrow neutrophil production that characterizes late phenotypic maturation[J]. Am J Physiol Regul Integr Comp Physiol, 2007, 292(4):R1707-R1716.
[25] Drifte, Geneviève, Dunn-Siegrist, et al. Innate immune functions of immature neutrophils in patients with sepsis and severe systemic inflammatory response syndrome[J]. Crit Care Med, 2013, 41(3):820-832.
[26] Maguer-Satta V, Besan?on R, Bachelard-Cascales E. Concise review: neutral endopeptidase(CD10): A multifaceted environment actor in stem cells, physiological mechanisms, and cancer[J]. Stem Cells, 2011, 29(3):389-396.
[27] Kaneko T, Stearns-Kurosawa DJ, Taylor F, et al. Reduced neutrophil CD10 expression in nonhuman primates and humans after in vivo challenge with E. coli or lipopolysaccharide[J]. Shock, 2003, 20(2):130-137.
[28] Daix T, Guérin E, Tavernier E, et al. Immature granulocytes: a risk factor of infection after cardiac surgery[J]. Cytometry B Clin Cytom, 2018, 94(6):887-894.
[29] Buter H, Bakker AJ, Kingma WP, et al. Plasma glutamine levels in patients after non-elective or elective ICU admission: an observational study[J]. BMC Anesthesiol, 2016, 16:15.
[30] Buter H, Koopmans M, Kemperman R, et al. Plasma glutamine levels before cardiac surgery are related to post-surgery infections; an observational study[J]. J Cardiothorac Surg, 2016, 11(1):155.
[31] Parry-Billings M, Baigrie RJ, Lamont PM, et al. Effects of major and minor surgery on plasma glutamine and cytokine levels[J]. Arch Surg, 1992, 127(10):1237-1240.
[32] Dieleman JM, Nierich AP, Rosseel PM, et al. Dexamethasone for Cardiac Surgery(DECS)Study Group. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial[J]. JAMA, 2012, 308(17):1761-1767.
[33] Whitlock RP, Devereaux PJ, Teoh KH, et al. Methylprednisolone in patients undergoing cardiopulmonary bypass(SIRS): a randomised, double-blind, placebo-controlled trial[J]. Lancet, 2015, 386(10000):1243-1253.
[34] Artinyan A, Orcutt ST, Anaya DA, et al. Infectious postoperative complications decrease long-term survival in patients undergoing curative surgery for colorectal cancer: a study of 12,075 patients[J]. Ann Surg, 2015, 261(3):497-505.